Annabel Kitowski

This paper shows that co-administering vascular disrupting agents with nanoparticle drugs increases tumoral uptake without increasing systemic exposure.

This paper develops a fluorogenic probe scaffold that retains fluorescent products within cells to improve imaging sensitivity and resolution for quantifying low-turnover biological processes.

The paper develops fluorogenic chemical probes that detect membrane damage without washing steps, enabling in vivo imaging of cell death mechanisms like ferroptosis and necrosis.